Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Monday 27 April, 2020

JP Morgan Sec LLC

AbbVie Inc. 38.5(b) Amendment

RNS Number : 9715K
J.P. Morgan Securities LLC
27 April 2020
 

Ap27

 

 

AMENDMENT

FORM   38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 

1.  KEY   INFORMATION

 

Nameofexemptprincipaltrader

J.P Morgan Securities LLC

Companydealtin

AbbVie Inc.

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 1)

Common stock

Date of dealing

23 April 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   2)

 

 

Long

Short

 

Number

 

(%)

Number

 

(%)

 11,431,672  0.77

 4,446,084  0.30

(2) Derivatives (other than options)

 3,507,411  0.24

 1,957,807  0.13

(3)Optionsandagreementstopurchase/sell

 751,400  0.05

 877,000  0.06

Total

  15,690,483  1.06

 7,280,891  0.49

             

 

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   2)

 

Classofrelevantsecurity:

Long

Short

 

Number

 

(%)

Number

 

(%)

 

 

(2) Derivatives (other than options)

 

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

 

 

             

 

Ap28

 

 

3.  DEALINGS  (Note   3)

 

(a)  Purchases and sales

 

Purchase/sale

Numberofrelevantsecurities

Priceperunit (Note 4)

Sale (Borrow Return)

 

Purchases

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

52,800

 

2,877

40

105

4

5,500

1

100

119

4,330

24,052

100

22

9

200

91

261

66

107

7

72

295

40

 

10,208

81

44

101

1,100

300

200

300

100

200

36

600

18

1,080

425

200

100

80

3,423

100

400

210

2,800

400

3,423

3,000

200

1,100

5,500

2,200

1,505

250

100

900

200

964

100

404

312

4,941

546

480

500

374

1,100

129

6,634

200

24,052

3,653

3,400

200

700

1,729

1,000

200

704

991

50

100

182

66

7

20

NA

 

82.0400 USD

82.2300 USD

82.2900 USD

82.5600 USD

82.5905 USD

82.7000 USD

82.7800 USD

82.7968 USD

82.8637 USD

82.9259 USD

83.0200 USD

83.0400 USD

83.0500 USD

83.1070 USD

83.1500 USD

83.2255 USD

83.2600 USD

83.2700 USD

83.2729 USD

83.2863 USD

83.5832 USD

83.7000 USD

 

82.0400 USD

82.0833 USD

82.0900 USD

82.1000 USD

82.1027 USD

82.1233 USD

82.1250 USD

82.1267 USD

82.1300 USD

82.1400 USD

82.1429 USD

82.1450 USD

82.1483 USD

82.1491 USD

82.1494 USD

82.1600 USD

82.1630 USD

82.1651 USD

82.1927 USD

82.2300 USD

82.2600 USD

82.2900 USD

82.3446 USD

82.3450 USD

82.3462 USD

82.3610 USD

82.3650 USD

82.5509 USD

82.5905 USD

82.5959 USD

82.6055 USD

82.6080 USD

82.6100 USD

82.6111 USD

82.6150 USD

82.6252 USD

82.6500 USD

82.6554 USD

82.6606 USD

82.6624 USD

82.6700 USD

82.6900 USD

82.6940 USD

82.6956 USD

82.7359 USD

82.8500 USD

82.9087 USD

82.9200 USD

82.9259 USD

82.9660 USD

83.0490 USD

83.0500 USD

83.0629 USD

83.0760 USD

83.0820 USD

83.1070 USD

83.1113 USD

83.1420 USD

83.2390 USD

83.2400 USD

83.2500 USD

83.2600 USD

83.2729 USD

83.7000 USD

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 5)

Numberofrelevantsecurities

(Note 6)

Priceperunit

(USD)

(Note 4)

Equity Swaps

Long

 

 

 

Short

33

5,500

24,052

 

200

7

20

82.0400

 82.5905

 82.9259

 

 83.1070

 83.2729

 83.7000

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing,   selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

(USD)

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (USD)

(Note 4)

Put Option

Selling

1,400

77.50

American

19JUN20

3.20

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 4)

 

 

 

 

 

(d)  Other   dealings   (including   transactions   in   respect   of   new   securities)   (Note   3)

 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

 

 

Ap29

 

4.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option 

referred   to   on   this   form   or   relating   to   the   voting   rights  or future acquisition or disposal of any relevant 

securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

Is a Supplemental Form 38.5(b) attached?  (Note   8)    YES

 

 

Dateofdisclosure

27 April 2020

Contactname

Alwyn Basch

Telephone number

020 7742 7407

Name of offeree/offeror with which connected

Allergan plc

Nature of connection (Note 9)

Financial Advisor to Allergan plc

 

 

 

 

 

Ap31

 

 

SUPPLEMENTAL   FORM   38.5(b)

 

 

 

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS   OF OPEN POSITIONS

 

(This   form   should   be   attached   to   Form   38.5(b))   OPEN POSITIONS  (Note   1)

 

Productname,

e.g. call option

Written orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price (Note 2)

Type, e.g.American,Europeanetc.

Expiry date

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

10,000

6,100

41,200

8,400

11,200

7,200

21,100

2,500

7,900

5,600

2,500

8,500

10,000

100,000

50,000

15,000

15,000

20,000

7,900

9,500

8,500

6,100

18,200

8,400

11,200

7,200

21,100

2,500

4,500

5,600

2,500

20,000

15,000

15,000

20,000

102,500

31,300

32,300

16,400

84,000

900

7,000

4,400

45,000

29,100

9,700

4,900

12,100

12,100

800

140,000

5,100

3,000

600

20,000

15,000

15,000

20,000

100,000

102,500

31,300

32,300

11,400

8,900

1,900

4,400

29,100

20,000

100,000

15,000

15,000

20,000

105.00

110.00

85.00

92.50

95.00

100.00

80.00

87.50

90.00

97.50

115.00

105.00

110.00

70.00

92.50

91.57

95.93

82.37

95.00

100.00

105.00

110.00

85.00

92.50

95.00

100.00

80.00

87.50

90.00

97.50

115.00

82.50

91.57

95.93

82.37

60.00

65.00

70.00

75.00

77.50

85.00

72.50

67.50

80.00

55.00

60.00

65.00

70.00

75.00

77.50

82.50

62.50

72.50

67.50

80.00

78.49

82.85

78.35

78.50

60.00

65.00

70.00

75.00

77.50

72.50

67.50

55.00

60.00

70.00

78.49

82.85

78.35

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

18SEP20

18SEP20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

24APR20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

 

 

 

 

Notes

 

1.  Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.  For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rules 8 and

38.5 of the Rules. If in doubt, consult the Panel.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEBGGDSLBDDGGR

a d v e r t i s e m e n t